UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058256
Receipt number R000066593
Scientific Title Preliminary Evaluation of the Association Between Sleep and Postprandial Blood Glucose Levels
Date of disclosure of the study information 2025/06/23
Last modified on 2025/08/19 14:18:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preliminary Evaluation of the Association Between Sleep and Postprandial Blood Glucose Levels

Acronym

Preliminary Evaluation of the Association Between Sleep and Postprandial Blood Glucose Levels

Scientific Title

Preliminary Evaluation of the Association Between Sleep and Postprandial Blood Glucose Levels

Scientific Title:Acronym

Preliminary Evaluation of the Association Between Sleep and Postprandial Blood Glucose Levels

Region

Japan


Condition

Condition

not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of the association between sleep and postprandial blood glucose levels.

Basic objectives2

Others

Basic objectives -Others

To assess the impact of sleep on postprandial glucose responses.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To examine whether glycemic control indicators are associated with sleep parameters.

Key secondary outcomes

Comparison of glycemic control indicators among subgroups defined by sleep characteristics.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food Other

Interventions/Control_1

Participants are instructed to consume a standardized breakfast (test food) as part of the intervention protocol

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Male and female over 20 years old

Key exclusion criteria

1) Persons undergoing treatment for diabetes or equivalent medical treatment (medication for blood glucose control, insulin injections, etc.).
2) Persons with food allergies to the test food.
3) Persons with implanted medical devices such as pacemakers.
4) Persons diagnosed with sleep-related disorders such as sleep apnea, insomnia, circadian rhythm sleep-wake disorders, or narcolepsy.
5) Any other person who is deemed inappropriate by the principal investigator.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Shige
Middle name
Last name Suzuki

Organization

KAGOME CO., LTD.

Division name

Diet & Well-being Research Institute

Zip code

3292762

Address

17, Nishitomiyama, Nasushiobara-shi, Tochigi

TEL

0287-36-2935

Email

Shigenori_Suzuki@kagome.co.jp


Public contact

Name of contact person

1st name Haruka
Middle name
Last name Yosdhida

Organization

KAGOME CO., LTD.

Division name

Diet & Well-being Research Institute

Zip code

3292756

Address

17, Nishitomiyama, Nasushiobara-shi, Tochigi

TEL

0287-36-2935

Homepage URL


Email

Haruka_Yoshida@kagome.co.jp


Sponsor or person

Institute

KAGOME CO., LTD

Institute

Department

Personal name



Funding Source

Organization

not applicable

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

KAGOME CO.,LTD, Research Ethics Review Committee

Address

3-21-1, Nihonbashi Hamacho, Chuo-ku, Tokyo

Tel

03-5623-8501

Email

IRB @kagome.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

カゴメ株式会社総合研究所(栃木県)


Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 06 Month 20 Day

Date of IRB

2025 Year 06 Month 20 Day

Anticipated trial start date

2025 Year 06 Month 30 Day

Last follow-up date

2025 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 23 Day

Last modified on

2025 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066593